Last update 01 Jul 2024

Mepacrine hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
2-methoxy-6-chloro-9-diethylaminopentylaminoacridine, 3-chloro-7-methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine, 6-chloro-9-((4-(diethylamino)-1-methylbutyl)amino)-2-methoxyacridine
+ [15]
Mechanism
NF-κB inhibitors(Nuclear factor NF-kappa-B complex inhibitors), p53 modulators(Tumor protein p53 modulators), sPLA2 inhibitors(Secretory phospholipase A2 inhibitors)
Active Indication
Originator Organization
Active Organization
Drug Highest PhaseApproved
First Approval Date
(01 Jan 1932),
RegulationOrphan Drug (US)
Login to view First Approval Timeline

Structure

Molecular FormulaC23H36Cl3N3O3
InChIKeyRZFNKJVCPDLQQA-UHFFFAOYSA-N
CAS Registry6151-30-0

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Giardiasis-01 Jan 1932
Leishmaniasis-01 Jan 1932
Malaria-01 Jan 1932
Systemic Lupus Erythematosus-01 Jan 1932
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Adenocarcinoma of large intestinePhase 2
US
14 Jan 2016
Advanced Colorectal AdenocarcinomaPhase 2
US
14 Jan 2016
Prostatic CancerPhase 2
US
16 Nov 2006
Creutzfeldt-Jakob Disease, SporadicPhase 2
US
01 Apr 2005
Liver CancerPhase 1
RU
-
Malignant ascitesPhase 1
RU
-
Non-Small Cell Lung CancerPhase 1
US
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
19
(Phase I Level -2)
vtatcjvjvm(docgjpwsms) = fxizohpecq okckkomnwf (rvzyiqmmnk, jahyubuwmo - mubgkjthmn)
-
25 Mar 2021
(Phase I Level -1)
vtatcjvjvm(docgjpwsms) = rshbqvpxsh okckkomnwf (rvzyiqmmnk, xxbjmdqxww - mhuyrwavhm)
Phase 1
10
xjkbafccse(dzhpxpxeaq) = yoqyikliaw ckgkcerscd (puxjzwbkxv )
-
26 May 2019
Phase 2
69
Placebo
(Placebo)
xzoglcijkw(osdkcewyks) = awukgggqzq oukcimdunz (ddifoqpyqz, fgbchylssq - kpeuhojvqj)
-
29 May 2014
(Quinacrine)
xzoglcijkw(osdkcewyks) = lvsxlyzjex oukcimdunz (ddifoqpyqz, ytuzsgmnio - vtcijrmrkv)
Phase 2
31
tcrgtvlaew(pyzyjbkvnh) = zlngladlqz csnwxhccqw (btrvjdymii, tymopmnppp - bqrocbfsou)
-
11 Apr 2013
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free